IMMUNIC, INC. — Director's Dealing 2024

Jun 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2024-06-11

Reporting Person: Neermann Joerg (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-11	Stock Option	$1.27	A	100000	Acquired	2034-06-11	Common Stock (100000)	Direct

Footnotes

F1: The option vests in monthly increments over a period of one year from the grant date.